NuCana PLC (NCNA)
4.00
+0.04
(+0.88%)
USD |
NASDAQ |
May 03, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
NuCana Free Cash Flow (Quarterly): 0.3701M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.3701M |
September 30, 2023 | -13.23M |
June 30, 2023 | -7.875M |
March 31, 2023 | -12.76M |
December 31, 2022 | -9.568M |
September 30, 2022 | 2.820M |
June 30, 2022 | -10.78M |
March 31, 2022 | -11.79M |
December 31, 2021 | -14.50M |
September 30, 2021 | -1.166M |
June 30, 2021 | -7.246M |
March 31, 2021 | -11.33M |
December 31, 2020 | -11.66M |
September 30, 2020 | -7.683M |
Date | Value |
---|---|
June 30, 2020 | -2.016M |
March 31, 2020 | -8.481M |
December 31, 2019 | -6.181M |
September 30, 2019 | -9.937M |
June 30, 2019 | -7.599M |
March 31, 2019 | -8.324M |
December 31, 2018 | -4.123M |
September 30, 2018 | -5.159M |
June 30, 2018 | -4.931M |
March 31, 2018 | -4.263M |
December 31, 2017 | -4.208M |
September 30, 2017 | -3.223M |
June 30, 2017 | -3.106M |
March 31, 2017 | -2.122M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-14.50M
Minimum
Dec 2021
2.820M
Maximum
Sep 2022
-7.927M
Average
-8.481M
Median
Mar 2020
Free Cash Flow (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | -15.50M |
Biodexa Pharmaceuticals Plc | -- |
Autolus Therapeutics PLC | -26.31M |
Mereo BioPharma Group PLC | -- |
Bicycle Therapeutics PLC | -47.34M |